# Bivalirudin with Prolonged Infusion During PCI Versus Heparin After Fibrinolytic Therapy

> **NCT06861374** · NA · NOT_YET_RECRUITING · sponsor: **First Affiliated Hospital Xi'an Jiaotong University** · enrollment: 2400 (estimated)

## Conditions studied

- ST-segment Elevation Myocardial Infarction (STEMI)

## Interventions

- **DRUG:** Bivalirudin
- **DRUG:** Unfractionated heparin

## Key facts

- **NCT ID:** NCT06861374
- **Lead sponsor:** First Affiliated Hospital Xi'an Jiaotong University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05
- **Primary completion:** 2028-03
- **Final completion:** 2029-03
- **Target enrollment:** 2400 (ESTIMATED)
- **Last updated:** 2025-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06861374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06861374, "Bivalirudin with Prolonged Infusion During PCI Versus Heparin After Fibrinolytic Therapy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06861374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*